Saturday, 5 September 2026European Markets

VINCI And FORESTIERE EQUAT. Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - vinci (dg.pa) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
vinci (dg.pa) €118.76 4.28% 16.61%
forestiere equat. (fore.pa) €645.00 0.72% 3.09%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. vinci (dg.pa)

4.28% forward dividend yield and 16.61% return on equity

vinci sa, together with its subsidiaries, engages in concessions, energy, and construction businesses in france and internationally. the concessions segment manages motorway concessions; operates airports; and highways, railways, and stadium. its energy segment provides services to the manufacturing sector, infrastructure, facilities management, and information and communication technology; and industrial and energy-related services, which includes development of renewable energy assets, as well as engineering, procurement, and construction projects in the energy sector. the construction segment engages in designing and carrying out projects, which includes general contractor; geotechnical and structural engineering and related digital activities, as well as provision of services in nuclear engineering; proximity networks with active local companies, such as building, civil engineering, roadworks, rail works, and water works; property development, including residential and commercial properties; and management of serviced residences and property services. vinci sa was founded in 1899 and is headquartered in nanterre, france.

earnings per share

as for profitability, vinci has a trailing twelve months eps of €8.18.

pe ratio

vinci has a trailing twelve months price to earnings ratio of 14.52. meaning, the purchaser of the share is investing €14.52 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.61%.

more news about vinci.

2. forestiere equat. (fore.pa)

0.72% forward dividend yield and 3.09% return on equity

la forestière equatoriale sa does not have any significant operations. the company is based in puteaux, france. la forestière equatoriale sa operates as a subsidiary of compagnie du cambodge.

earnings per share

as for profitability, forestiere equat. has a trailing twelve months eps of €3.74.

pe ratio

forestiere equat. has a trailing twelve months price to earnings ratio of 172.46. meaning, the purchaser of the share is investing €172.46 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.09%.

revenue growth

year-on-year quarterly revenue growth grew by 4200%, now sitting on 18.24k for the twelve trailing months.

moving average

forestiere equat.'s value is below its 50-day moving average of €682.90 and below its 200-day moving average of €657.80.

more news about forestiere equat..

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com